Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 49 for “"Epigenetic therapy"”.

  1. Epigenetic Therapy as a Primer for Immunotherapy

    … agents (HMAs) are at the forefront of epigenetic modulators for cancer treatments. As single agents, their efficacy is mainly appreciated in hematological studies prompting the development of second-generation DNA methylation inhibitors and drug delivery avenues. One of the mechanisms …

    toronto-retro Repository record for Epigenetic Therapy as a Primer for Immunotherapy (opens in a new tab)

  2. COMBINATION EPIGENETIC THERAPY CAN SENSITIZE OVARIAN CANCER TO IMMUNE CHECKPOINT THERAPY

    … between the tumor, immune system, and immunotherapy, it is necessary to use an immunocompetent model of ovarian cancer. Therefore, we characterized four related syngeneic epithelial ovarian cell lines, MOSEC, Roby-ID8-luc2, Roby-ID8-nonluc, and ID8-VEGF-defensin, that can form tumors in …

    jhu Repository record for COMBINATION EPIGENETIC THERAPY CAN SENSITIZE OVARIAN CANCER TO IMMUNE CHECKPOINT THERAPY (opens in a new tab)

  3. Assessing Epigenetic Therapy in Preclinical Models of Non-small Cell Lung Cancer

    Epigenetic dysregulation, including aberrant DNA hypermethylation and histone deacetylation, and associated silencing of tumor suppressor genes, is critically involved in the development of non-small cell lung cancer (NSCLC). Targeting key regulators of these processes, DNA methyltransferases and …

    jhu Repository record for Assessing Epigenetic Therapy in Preclinical Models of Non-small Cell Lung Cancer (opens in a new tab)

  4. Epigenetic therapy based on micrornas inhibition for the amelioration of masld phenotype

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently the most prevalent liver disorder worldwide. In Europe, around 25% of people suffer from this disease. It is strongly associated with several comorbidities, including obesity, type 2 diabetes mellitus, and metabolic …

    sevilla Repository record for Epigenetic therapy based on micrornas inhibition for the amelioration of masld phenotype (opens in a new tab)

  5. Epigenetic therapy using targeted microbubbles as a potential treatment for breast cancer

    … (MBs) to enhance therapeutic effects of an epigenetic drug, called decitabine (5-aza-2'-deoxycytidine or DAC), against triple-negative breast cancer (TNBC). MB-assisted drug delivery using ultrasound is proposed as a non-invasive approach for controllably triggered drug release, which may …

    whiterose Download PDF for Epigenetic therapy using targeted microbubbles as a potential treatment for breast cancer (opens in a new tab)

  6. EPIGENETIC THERAPY TIES MYC DEPLETION TO REVERSING IMMUNE EVASION AND TREATING LUNG CANCER

    … holds promise for enhancing cancer immune therapy. Herein, pharmacologic and isoform specificity of HDACi’s are investigated to guide their addition to a DNMTi, thus devising a new, low-dose, sequential regimen which imparts a robust anti-tumor effect for non-small cell lung cancer (NSCLC). …

    jhu Repository record for EPIGENETIC THERAPY TIES MYC DEPLETION TO REVERSING IMMUNE EVASION AND TREATING LUNG CANCER (opens in a new tab)

  7. Investigating the role of epigenetic therapy in chemotherapy-resistant triple-negative breast cancer

    … treatment options are limited. While chemotherapy is currently the standard-of-care therapy, almost half of patients develop chemotherapy resistance, leading to high rates of relapse and poor clinical outcomes. This highlights a need for more effective therapeutic options for …

    toronto-retro Repository record for Investigating the role of epigenetic therapy in chemotherapy-resistant triple-negative breast cancer (opens in a new tab)

  8. Epigenetic changes during acute oxidative damage and non-small cell lung cancer epigenetic therapy

    … exhibit not only genetic abnormalities but also epigenetic ones which consist of DNA methylation and chromatin alterations. Among the key cancer specific changes involving interplay of these epigenetic parameters are simultaneous wide spread losses of DNA methylation and more focal gains at CpG …

    jhu Repository record for Epigenetic changes during acute oxidative damage and non-small cell lung cancer epigenetic therapy (opens in a new tab)

  9. Irradiation of the microenvironment affects epigenetic therapy by LSD1 inhibition in murine AML model

    … in treating Acute myeloid leukemia (AML). Chemotherapy (in combination with additional substances) is often not enough to achieve a long-lasting complete remission. Because of that an allogenic stem cell transplantation is required, which is often done after a total body irradiation. Moreover, …

    lmu-germany Repository record for Irradiation of the microenvironment affects epigenetic therapy by LSD1 inhibition in murine AML model (opens in a new tab)

  10. Resveratrol And Pterostilbene: A Novel Combinatorial Epigenetic Therapy In Targeting Triple-Negative Breast Cancer

    … cells individually via affecting genetic and epigenetic profiles, but none of the studies to date have addressed the effects of these two compounds in combination in targeting triple-negative breast cancers (TNBC). We have discovered a synergistic effect of these two compounds when …

    uab Repository record for Resveratrol And Pterostilbene: A Novel Combinatorial Epigenetic Therapy In Targeting Triple-Negative Breast Cancer (opens in a new tab)

  11. Leveraging Polyamine Metabolic Stress to Enhance Sensitivity to an Epigenetic Therapy for Prostate Cancer

    … that this stress will alter CaP sensitivity to epigenetic based drugs. While epigenetic therapies are currently being investigated in the clinic for targeting CaP, their success has been limited due to toxicity and non-specificity. We hypothesize that increased flux through polyamine metabolism …

    buffalo Repository record for Leveraging Polyamine Metabolic Stress to Enhance Sensitivity to an Epigenetic Therapy for Prostate Cancer (opens in a new tab)

  12. Preclinical evaluation of histone deacetylase inhibitors for epigenetic therapy of diffuse large B-cell lymphoma

    This dissertation evaluates the therapeutic potential of newly synthesized histone deacetylase inhibitors (HDACi) for the treatment of diffuse large B-cell lymphoma (DLBCL). The study focused on the preclinical assessment of 41 HDACi across various lymphoma cell lines. Among these, YAK477 emerged …

    lmu-germany Repository record for Preclinical evaluation of histone deacetylase inhibitors for epigenetic therapy of diffuse large B-cell lymphoma (opens in a new tab)

  13. Epigenetic Therapy of Lung Cancers: Anti-tumoral effect of valproate on small cell lung cancer

    Lung cancer is the leading cause of cancer-related death worldwide. Among lung carcinomas, the outcome of small cell lung carcinoma (SCLC) patients is the poorest of any histological subtype with five-year survival rate of less than 20 and 5 % for limited and extensive stage respectively. Based on …

    liege Repository record for Epigenetic Therapy of Lung Cancers: Anti-tumoral effect of valproate on small cell lung cancer (opens in a new tab) Restricted access

  14. IMPROVING MANAGEMENT OF NON-SMALL CELL LUNG CANCER BY TARGETING THE STAT3 PATHWAY IN COMBINATION WITH EPIGENETIC THERAPY

    … antigens that can be recognized by T cells. An epigenetic therapy-based approach has been developed in our lab to enhance expression of tumor antigens utilizing combinatorial DNA methyltransferase inhibition (DNMTi) paired with histone deacetylase inhibition (HDACi). However, durable responses …

    jhu Repository record for IMPROVING MANAGEMENT OF NON-SMALL CELL LUNG CANCER BY TARGETING THE STAT3 PATHWAY IN COMBINATION WITH EPIGENETIC THERAPY (opens in a new tab) Embargoed until 2027-05-01

  15. Epigenetinis reguliavimas ir leukemija – naujų biologinių, molekulinių ir terapinių aspektų tyrimai /

    … However, despite the general success of RA therapy, RA treatment resistant cases still remain a serious issue. It has been demonstrated that epigenetic remodelling could overcome APL resistance to RA. Moreover, it is known that limited efficacy of RA treatment in other types of leukemias …

    vilnius Repository record for Epigenetinis reguliavimas ir leukemija – naujų biologinių, molekulinių ir terapinių aspektų tyrimai / (opens in a new tab)

  16. Epigenetic regulation and leukaemia – research of novel biological, molecular and therapeutic aspects /

    … However, despite the general success of RA therapy, RA treatment resistant cases still remain a serious issue. It has been demonstrated that epigenetic remodelling could overcome APL resistance to RA. Moreover, it is known that limited efficacy of RA treatment in other types of leukemias …

    vilnius Repository record for Epigenetic regulation and leukaemia – research of novel biological, molecular and therapeutic aspects / (opens in a new tab)

  17. Understanding p53 Regulation on Transposable Elements in Cancer

    … the relationship between p53 and TE under epigenetic therapy. Epigenetic therapy such as DNMTi and HDACi had passed clinical trials and been utilized in treating cancers. However the lack of their efficacy on other cancer types and certain patient populations remains puzzling. TEs are …

    wustl Repository record for Understanding p53 Regulation on Transposable Elements in Cancer (opens in a new tab)

  18. The function of PRC2 in MLL-AF4 acute lymphoid leukaemia

    … overall survival of 10 months in children. Epigenetic therapy is a promising new approach for the treatment haematological malignancies. Predicting response to epigenetic therapy has been difficult, in part due to the lack of sufficient knowledge regarding the molecular mechanism by which …

    oxford Repository record for The function of PRC2 in MLL-AF4 acute lymphoid leukaemia (opens in a new tab)

  19. Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer

    … we discovered that CDK9 inhibition reactivates epigenetically silenced genes in cancer, leading to restored tumor suppressor gene expression and cell differentiation, along with activation of endogenous retrovirus (ERV) genes. CDK9 inhibition results in dephorphorylation of the SWI/SNF protein …

    temple Repository record for Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer (opens in a new tab)

Page 1 of 3